95 results
Page 3 of 5
8-K
EX-2.1
5j0nfj5elu0l
19 Apr 21
Entry into a Material Definitive Agreement
1:44pm
424B5
0tjq38d s80nwv
8 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
6fo8w8yc36ijy rtrld
5 Feb 21
Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock
5:15pm
424B5
qki67st428 sjf9a
4 Feb 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.01
fcki3tx
3 Feb 21
Entry into a Material Definitive Agreement
9:07am
424B5
harhrcd qkfe9
21 Jan 21
Prospectus supplement for primary offering
8:27am
8-K
ql9mvjnaseo3f2
16 Dec 20
Oncocyte and Burning Rock Execute Strategic Agreement to Distribute Determarx In China
6:00am
PRER14A
627v21sgm94
18 May 20
Preliminary revised proxy
6:06am
8-K
mg05yv
12 May 20
Oncocyte Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:42pm
8-K
EX-10.2
ss5dyb1d
12 May 20
Oncocyte Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:42pm
8-K
EX-10.1
rc42d0w6 nqu
12 May 20
Oncocyte Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:42pm
8-K
EX-10.3
oc80 gb0wkn59d
12 May 20
Oncocyte Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:42pm